Trials / Completed
CompletedNCT01006759
Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients
Proposal Evaluation and Intervention Through Prevention of Disability in Leprosy Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Leprosy is an infectious disease of slow evolution, manifested primarily by signs and symptoms dermatoneurological with skin lesions and peripheral nerve, especially in the eyes, hands and feet. The prevention of disability is essential for the control of complications. Objective: To evaluate the physical and functional status of hands, feet and eyes, for the appearance and evolution of sensory and motor deficiencies and classification of disability (WHO) of a group of leprosy patients to compare and monitor the result treatment on the progression of neuropathy and recurrence of reactions. Methodology: We performed initial physical therapy evaluation and final, after 12 months. We conducted a clinical trial of a series of 26 cases evaluated with newly diagnosed leprosy, treated by standard medication. There were used methods of qualitative and quantitative. An illustrated manual of guidelines was especially developed for this study.
Detailed description
assessment methods of qualitative and quantitative: inspection of eyes, hands and foot, manual motor function, grip and pinch dynamometry,threshold test, SF 36 quality of life questionnaire. Intervention: illustrated guidelines, exercises, orthoses, orientation Goals: disability prevention
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | exercise and orientation | guidances for prevention of disability in leprosy with focus on hands, eyes and feet. |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2008-12-01
- Completion
- 2009-08-01
- First posted
- 2009-11-03
- Last updated
- 2009-11-03
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01006759. Inclusion in this directory is not an endorsement.